S&P 500: 681.75 +0.1% NASDAQ 100: 601.92 +0.2% Dow Jones: 495.28 +0.1%

Steven Cohen’s TNGX Holdings & Trades

First Buy
Q1 2023
Duration Held
5 Quarters
Largest Add
Q3 2025
+2.92 M Shares
Current Position
2.92 M Shares
$24.52 M Value

Steven Cohen's TNGX Position Overview

Steven Cohen (via Point72 Asset Management, L.P.) currently holds 2.92 M shares of Tango Therapeutics, Inc. (TNGX) worth $24.52 M, representing 0.04% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 5 quarters.

Based on 13F filings, Steven Cohen has maintained this position in TNGX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 2.92 M shares. Largest reduction occurred in Q3 2024, reducing 447,107 shares.

Analysis based on 13F filings available since 2013 Q2

Steven Cohen's Tango Therapeutics (TNGX) Holding Value Over Time

Track share changes against reported price movement

Quarterly Tango Therapeutics (TNGX) Trades by Steven Cohen

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2023 +7,346 New Buy 7,346 $3.95
Q2 2023 -7,346 Sold Out 0 $0.00
Q2 2024 +447,107 New Buy 447,107 $8.58
Q3 2024 -447,107 Sold Out 0 $0.00
Q3 2025 +2.92 M New Buy 2.92 M $8.40

Steven Cohen's Tango Therapeutics Investment FAQs

Steven Cohen first purchased Tango Therapeutics, Inc. (TNGX) in Q1 2023, acquiring 7,346 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Steven Cohen has held Tango Therapeutics, Inc. (TNGX) for 5 quarters since Q1 2023.

Steven Cohen's largest addition to Tango Therapeutics, Inc. (TNGX) was in Q3 2025, adding 2,919,450 shares worth $24.52 M.

According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 2,919,450 shares of Tango Therapeutics, Inc. (TNGX), valued at approximately $24.52 M.

As of the Q3 2025 filing, Tango Therapeutics, Inc. (TNGX) represents approximately 0.04% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.

Steven Cohen's peak holding in Tango Therapeutics, Inc. (TNGX) was 2,919,450 shares, as reported at the end of Q3 2025.